Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-06 Sale |
2024-03-08 7:25 pm |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
45,257 | $66.1 | $2,991,469 | 411,629 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-07 9:42 pm |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
24,338 | $66.37 | $1,615,313 | 122,458 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 9:11 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
40,000 | $65.77 | $2,630,864 | 916,272 (Indirect Direct) |
View |
| 2024-03-05 Sale |
2024-03-06 4:24 pm |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
5,000 | $66 | $330,000 | 87,387 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:20 pm |
ANI PHARMACEUTICALS INC | ANIP | Pera Antonio R Director |
7,000 | $65.2 | $456,400 | 26,627 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-13 8:05 pm |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
250 | $56.04 | $14,010 | 36,799 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-23 5:32 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,216 | $56.17 | $1,416,466 | 935,027 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:20 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
24,784 | $55.29 | $1,370,305 | 960,243 (Indirect Direct) |
View |
| 2024-01-12 Sale |
2024-01-16 9:09 pm |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
250 | $56.43 | $14,108 | 37,049 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 5:44 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $52.55 | $2,627,250 | 985,027 (Indirect Direct) |
View |
| 2023-12-11 Sale |
2023-12-11 5:49 pm |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
250 | $49.21 | $12,303 | 37,299 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 9:05 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
13,000 | $51 | $663,000 | 1,035,027 (Indirect Direct) |
View |
| 2023-11-14 Sale(A) |
2023-11-20 8:58 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
37,000 | $53 | $1,961,148 | 995,620 (Indirect) |
View |
| 2023-11-15 Sale |
2023-11-16 6:13 pm |
ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER |
2,622 | $53.81 | $141,090 | 32,587 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 6:11 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
36,190 | $53 | $1,918,080 | 1,048,837 (Indirect Direct) |
View |
| 2023-11-13 Sale |
2023-11-14 5:04 pm |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
250 | $52.03 | $13,008 | 37,549 (Direct) |
View |
| 2023-11-10 Sale |
2023-11-13 4:02 pm |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
3,000 | $52.47 | $157,410 | 63,607 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 4:28 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,000 | $57.75 | $1,443,869 | 1,085,027 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-07 Tax Withholding |
2024-03-08 7:25 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
17,060 | $66.71 | 411,629 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-07 9:42 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
2,034 | $66.71 | 122,458 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-07 9:21 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
2,494 | $66.71 | 80,212 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-07 9:16 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
2,110 | $66.71 | 85,277 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:18 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
1,122 | $67.67 | 956,272 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:12 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
1,275 | $67.67 | 92,387 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:09 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
1,058 | $67.67 | 148,830 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:06 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
10,014 | $67.67 | 473,946 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:03 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
1,570 | $67.67 | 82,706 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 5:01 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
1,635 | $67.67 | 342,905 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 4:59 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER |
1,173 | $67.67 | 51,545 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 4:57 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
1,173 | $67.67 | 60,231 (Direct) |
View |
| 2024-02-29 Tax Withholding |
2024-03-01 4:55 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO |
1,914 | $67.67 | 189,715 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-20 5:09 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
1,244 | $57.55 | 84,276 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-20 5:02 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
1,261 | $57.55 | 93,662 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:56 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
134,216 | $0 | 483,960 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:53 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
22,367 | $0 | 957,394 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:50 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
31,316 | $0 | 94,923 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:47 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
16,776 | $0 | 149,888 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:38 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
24,605 | $0 | 85,520 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:34 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
22,367 | $0 | 344,540 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER |
20,131 | $0 | 52,718 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:28 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
24,605 | $0 | 61,404 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:26 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO |
35,790 | $0 | 191,629 (Direct) |
View |